The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception -- including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback